Figure 1. Global Fund Strategy Framework
|
Types of RSSH Investments
|
Figure 2. Scale-Up of RSSH-PPR Investments in Grant Cycle 7
Country Coordinating Mechanisms (CCMs) are rationally using the C19RM to resolve the tension between increasing RSSH investment and sustaining investment levels across the diseases as funding for them flatlined. In Mali, for instance, reinvestment of the C19RM will allow for increased multi-disease testing capacity, through the establishment of a computerized national logistics management information systems interoperable with the district health information system. Portfolio optimization will include strengthening the decentralization of diagnosis and the development of a national plan for integrated sample transportation and a national multi-risk action plan. These will go hand-in-hand with capacity building training across all levels with quality assurance and improve analysis of data to monitor and respond to public health emergencies.
Positive Trend for Human Resources for Health Strategic Investments
There was an overall increase in the supervision of human resources for health, training and governance investments. A preliminary analysis of a sample of 31 RSSH priority countries showed a growth in support to maintaining a pipeline of health workers and in the quantity and quality of community health workers’ investment. There was also good uptake of new, more evidence-based interventions.
Enhanced intentional RSSH-PPR investments in target areas
As compared to the GC6, in GC7, countries fully utilized the matching funds they were eligible for and doubled budgets for human resources in health and lab systems. This in turn led to the strengthening of health systems’ human resources (in areas of governance, data and analytical capacity to plan for their better deployment, distribution, performance and retention) and better lab systems (including sample transport, diagnostic network optimization and lab data systems). Targeted health facility assessment planning is also on track to measure their integration, people-centered care and other key results for C19RM and GC7.
Implementation Snafus
Diffused Focus
The slow uptake of investments by countries in the GC6 as compared to GC7 was the result of fragmentation across donors and agencies, with no functional coordinating and accountability mechanisms or link to robust national plans. Furthermore, RSSH-PPR entities are not leading implementation and hence, RSSH investments get divested from programmatic focus. Technical assistance remained uneven or delayed and is often driven by the priorities of the donor rather than of the country. Administrative hurdles may also have blocked, for instance, integrated laboratory systems strengthening.
Poor Monitoring and Evaluation
RSSH indicators were poorly defined without clear linkage with investments, and were not used for Performance Frameworks in GC6.
Capacity Challenges
A potential 2 billion USD for C19RM available funding, combined with GC7, enables approximately a third of the entire funds to be available for RSSH-PPR activities during the GC7 period. Hence, it is implementation capacity, rather than insufficient funds, which is the key constraint at present.
Accelerating Implementation
In response to the above bottlenecks, direct RSSH for GC7 demonstrates more targeted and less fragmented investments than past cycles. Further, during GC6 itself, a very targeted engagement was initiated with high-risk countries to accelerate implementation (Figure 3).
Figure 3. In Country Absorption (ICA) Gap, 6th Replenishment Cycle
Review of contributory RSSH investments
In GC6 most contributory RSSH came from TB and TB/HIV grants with largest cost inputs being salaries and training. The share of contributory RSSH increased from 12% in GC6 to 13% in GC7 and is set to increase further with potential additions to contributory RSSH for activities that contribute to systems beyond a single disease. These could include, to name a few, comprehensive sexual education and social protection interventions (HIV), reforming policies, regulations and laws (TB); intensified activities for elimination and post-discharge chemoprevention (malaria). Best Practices in RSSH|
Mozambique’s strong leadership at the ministerial level and within the CCM saw a significant increase (22%) in RSSH investments in GC7 and is likely to also receive C19RM funding for RSSH activities. Their inclusive planning process of funding request design and grant-making is a strength and grant-making is focusing on facilitating further integration opportunities across the RSSH spectrum. During GC6, Secretariat set-up quarterly meetings in Mozambique for RSSH workplan review. Each Directorate receiving RSSH support prepared quarterly reports against the milestones to submit to the Secretariat for review in facilitating further integration. |
|
Indonesia created an ambitious health transformation roadmap to strengthen RSSH and expand integrated primary healthcare services. Indonesia increased provincial and district government capacity to develop health workplans/budgets that correspond to minimum standards, including for the three diseases, and enhanced involvement of multisectoral parties in their development. Indonesia introduced a hub-and-spoke model for whole genome sequencing and bio-banking at the district level. A “one health” platform consolidates health information by integrating all disease-specific data systems. Rigorous in-service training and integrated supportive supervision and human resource planning and management were undertaken, which will contribute to the effective scale up of IPCS from 9 to 40 districts in GC7 increasing disease coverage services at the community level. |
|
Post-Covid Strategic Priorities
Action Points
|
No comments yet. Be the first to comment!